Atria Investments’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.51M | Sell |
105,655
-40,415
| -28% | -$1.81M | 0.05% | 416 |
|
|
2026
Q1 | $7.04M | Buy |
146,070
+13,354
| +10% | +$623K | 0.08% | 277 |
|
|
2025
Q4 | $6.43M | Buy |
132,716
+15,416
| +13% | +$764K | 0.07% | 298 |
|
|
2025
Q3 | $5.54M | Sell |
117,300
-16,347
| -12% | -$789K | 0.06% | 355 |
|
|
2025
Q2 | $6.46M | Buy |
133,647
+14,475
| +12% | +$740K | 0.08% | 298 |
|
|
2025
Q1 | $6.61M | Buy |
119,172
+13,139
| +12% | +$711K | 0.08% | 275 |
|
|
2024
Q4 | $5.11M | Sell |
106,033
-1,263
| -1% | -$64.2K | 0.06% | 338 |
|
|
2024
Q3 | $6.18M | Buy |
107,296
+701
| +0.7% | +$37.8K | 0.08% | 296 |
|
|
2024
Q2 | $5.17M | Buy |
106,595
+7,717
| +8% | +$372K | 0.07% | 322 |
|
|
2024
Q1 | $4.81M | Buy |
98,878
+23,463
| +31% | +$1.15M | 0.07% | 346 |
|
|
2023
Q4 | $3.75M | Buy |
75,415
+624
| +0.8% | +$30.5K | 0.06% | 373 |
|
|
2023
Q3 | $4.01M | Buy |
74,791
+9,694
| +15% | +$517K | 0.07% | 341 |
|
|
2023
Q2 | $3.51M | Buy |
65,097
+9,217
| +16% | +$496K | 0.06% | 370 |
|
|
2023
Q1 | $3.04M | Buy |
55,880
+20,084
| +56% | +$977K | 0.06% | 399 |
|
|
2022
Q4 | $1.73M | Buy |
35,796
+8,166
| +30% | +$358K | 0.04% | 561 |
|
|
2022
Q3 | $1.05M | Sell |
27,630
-16,245
| -37% | -$724K | 0.02% | 706 |
|
|
2022
Q2 | $2.19M | Buy |
43,875
+1,146
| +3% | +$60.8K | 0.05% | 470 |
|
|
2022
Q1 | $2.19M | Buy |
42,729
+1,483
| +4% | +$76.6K | 0.04% | 536 |
|
|
2021
Q4 | $2.07M | Buy |
41,246
+115
| +0.3% | +$5.69K | 0.04% | 550 |
|
|
2021
Q3 | $1.98M | Buy |
41,131
+5,970
| +17% | +$304K | 0.04% | 533 |
|
|
2021
Q2 | $1.85M | Buy |
35,161
+6,701
| +24% | +$350K | 0.04% | 531 |
|
|
2021
Q1 | $1.41M | Buy |
28,460
+1,521
| +6% | +$73.1K | 0.03% | 581 |
|
|
2020
Q4 | $1.31M | Buy |
26,939
+2,571
| +11% | +$127K | 0.03% | 573 |
|
|
2020
Q3 | $1.22M | Buy |
24,368
+3,901
| +19% | +$201K | 0.04% | 503 |
|
|
2020
Q2 | $1.04M | Buy |
20,467
+3,235
| +19% | +$157K | 0.04% | 502 |
|
|
2020
Q1 | $753K | Buy |
17,232
+2,597
| +18% | +$124K | 0.06% | 272 |
|
|
2019
Q4 | $735K | Buy |
+14,635
| New | +$686K | 0.02% | 652 |
|
|
2019
Q3 | – | Sell |
-5,325
| Closed | -$225K | – | 957 |
|
|
2019
Q2 | $225K | Buy |
+5,325
| New | +$226K | 0.01% | 860 |
|
|
2018
Q4 | – | Sell |
-8,957
| Closed | -$400K | – | 998 |
|
|
2018
Q3 | $400K | Buy |
8,957
+367
| +4% | +$15.7K | 0.02% | 664 |
|
|
2018
Q2 | $344K | Sell |
8,590
-2,165
| -20% | -$85.2K | 0.02% | 690 |
|
|
2018
Q1 | $431K | Buy |
10,755
+1,011
| +10% | +$42.1K | 0.02% | 558 |
|
|
2017
Q4 | $419K | Sell |
9,744
-1,686
| -15% | -$77.7K | 0.02% | 531 |
|
|
2017
Q3 | $569K | Buy |
11,430
+3,339
| +41% | +$162K | 0.03% | 431 |
|
|
2017
Q2 | $388K | Buy |
8,091
+705
| +10% | +$33.7K | 0.02% | 492 |
|
|
2017
Q1 | $334K | Buy |
7,386
+602
| +9% | +$25.5K | 0.02% | 489 |
|
|
2016
Q4 | $274K | Buy |
+6,784
| New | +$267K | 0.02% | 501 |
|
|
2016
Q1 | – | Sell |
-5,593
| Closed | -$226K | – | 486 |
|
|
2015
Q4 | $226K | Sell |
5,593
-507
| -8% | -$23.3K | 0.02% | 367 |
|
|
2015
Q3 | $290K | Buy |
6,100
+1,120
| +22% | +$57K | 0.04% | 271 |
|
|
2015
Q2 | $247K | Buy |
4,980
+592
| +13% | +$30K | 0.03% | 344 |
|
|
2015
Q1 | $217K | Buy |
+4,388
| New | +$210K | 0.02% | 376 |
|
Other funds holding SNY
MIP
BIP
Atria Investments's SNY Position: Q2 2026 in Review
Atria Investments reduced its Sanofi (SNY) stake by 28% in Q2 2026, selling an estimated $1.81M and leaving 105,655 shares worth $4.51M. The position accounts for 0.05% of the portfolio, ranked #416.
Atria Investments first reported a position in SNY in Q1 2015 and has held it in 40 quarters since. The position peaked at $7.04M in Q1 2026. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Atria Investments held 105,655 shares of Sanofi worth $4.51M as of Q2 2026.
- Atria Investments sold 40,415 Sanofi shares in Q2 2026, an estimated $1.81M.
- Sanofi made up 0.05% of Atria Investments's portfolio in Q2 2026, its #416 holding.
- Atria Investments first reported a position in Sanofi in Q1 2015 and has held it in 40 quarters since.
- Atria Investments's Sanofi position peaked at $7.04M in Q1 2026.
- 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.